Largest disclosed lower bound
Gilbert Ray Cisneros, Jr. · $1.0K–$15.0K
Purchase · traded 2026-07-10 → filed 2026-09-04. Ranked over every BCRX row by the provable lower bound, never a point estimate.
Public record / Tickers / BCRX
BCRX — BIOCRYST PHARMACEUTICALS INC†
Both disclosure regimes on one name: who in Congress filed about BCRX, which institutions reported holding it. Each section keeps its own clock — congressional trades on the 45-day PTR clock, 13F holdings as quarter-end snapshots.
- Congress txns
- 5 all PTR rows naming BCRX
- Members · 12m
- 1 2 buys · 0 sells · by trade date
- Latest PTR
- 09-04 filed 2026-09-04
- 13F holders
- 287 top-287 slice · 2026-03-31
Congress = transactions in statutory ranges, 45-day lag · Institutions = quarter-end positions, 45-day lagas of 2026-09-14 13:21 UTCno price data — a disclosure record, not a chart
Congress · trailing 12 months
1 member · 2 buys / 0 sells
Counts of disclosures by trade date, not dollars — ranges cannot be netted across members. Flow ranges per member are in the table below.
Late filings
1 row filed past the 45-day window
Late disclosure is stated on the row, never editorialised. Both dates and the receipt stay on every row.
Congress · disclosure timeline
TRADE DATES · 24M · ▲ BUY ▼ SELL · HEIGHT = LOG LOWER BOUND2 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds.
Trade date, not filing date — the lag lives in the table below. 2 rows placed.
PLANNED institutional holder flow by quarter
Congressional disclosures
ALL PTR ROWS NAMING BCRX · SORTED FILED ↓ · STATUTORY RANGES · FILED ≤45D LATEfull congressional view ↗| Filed ▾ | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2026-09-04 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 07-10 LATE·56d | $1K–$15K | ||
| 2025-12-15 | Gilbert Ray Cisneros, Jr. D–CA-31 | Purchase | Traded 11-13 +32d | $1K–$15K | ||
| 2023-11-11 | Josh Gottheimer D–NJ-5 | Purchase · JT (jointly owned) | Traded 10-16 +26d | $1K–$15K | ||
| 2023-10-15 | Josh Gottheimer D–NJ-5 | Sale · JT (jointly owned) | Traded 09-15 +30d | $1K–$15K | ||
| 2022-09-16 | Josh Gottheimer D–NJ-5 | Purchase · JT (jointly owned) | Traded 08-11 +36d | $1K–$15K |
Traded → filed dates on every rowEach row shows the trade date and the filing date; the gap between them is the disclosure lag.all 5 ↗
Members active in BCRX
12M · NET LOWER BOUND · COMMITTEES AS OF TRADE DATE · SNAPSHOT 2026-09-14| Member | Rows | NetNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point. | CommitteesNumber of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join. |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D–CA-31 | 2 | $2.0K to $30.0K | 2 |
1 members in the window · counts of disclosures, not dollars.
Congress ↔ notable managers · BCRX
who in Congress disclosed purchases or sales beside which notable managers added or trimmedCongress · last 90 days
- Buyers
- 1 Gilbert Ray Cisneros, Jr. D–CA-31 $1K–$15K
- Sellers
- 0 — —
filed 2026-06-16 → 2026-09-14 · totals are statutory ranges
Notable managers · quarter ended 2026-03-31
- Adding
- 2 Bridgewater Associates, Gotham Asset Management $9.1M held
- Trimming
- 1 Caxton Associates $196K held
new + add vs trim + exit, by shares · $ = reported value now, not the change · BIOCRYST PHARMACEUTICALS INC
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-09-04 | Gilbert Ray Cisneros, Jr. Congress | Purchase | $1K–$15K |
| 2026-05-15 | Bridgewater Associates 13F | add | +402,482 sh |
| 2026-05-15 | Gotham Asset Management 13F | add | +96,015 sh |
| 2026-05-14 | Caxton Associates 13F | trim | −17,577 sh |
4 newest rows · Congress rows date by filing, 13F rows by quarter end · a 13F row is a quarter-end snapshot, not a trade
Institutional holders · 13F · Quarter ended 2026-03-31 · longs only
The published aggregate ranks the top 287 holders per issuer — a build parameter of the Public Filings aggregation, not a census. Rows beyond it exist in individual filings on EDGAR. methodology §13F ↗
§ derived by Public Filings from the published aggregate (agg_issuer_top_holders); per-filer filed dates, share counts and document links are not in the published aggregate — the EDGAR link opens the filer's 13F list
n/c Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.
Do the two regimes agree?
TRAILING 12M · CONGRESS vs FILERS NETCongress net (rows)2 buy / 0 sell
Congress net ($ bound)$2.0K to $30.0K
Filers net (actions)not in build
Filers net ($ Q/Q)not in build
The filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.
Signals on BCRX
RETAINED WINDOW · ACTIVE HITS| Kind | Rule | Hits |
|---|---|---|
| COMMITTEE | a disclosed trade in an issuer whose sector falls within a committee the member sat on as of the trade date (versioned mapping; membership dated) — context only: no legal, ethical, or causal conflict is established or implied | 1 hit |
Planned modules for BCRX · financials and macro
Financials — as filed PLANNED
BCRX's as-reported XBRL fundamentals will appear here when the financials module passes its gates. Until then: BCRX on EDGAR ↗
Macro context PLANNED
Rates, inflation, and positioning series land here with the macro module — vintage-aware, never nowcast.
† issuer name from the SEC's present-day ticker file (company_tickers.json) — a present-day mapping, not the name as of each filing